EQRX — EQRx Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMid Cap
EQRx Inc expected to post a loss of 24 cents a share - Earnings Preview
U.S. RESEARCH ROUNDUP-Bankunited, Eqrx, Syneos Health
Jefferies sees high likelihood of U.S. approval for four China-developed drugs
Rejection of Lilly's cancer drug likely to cast shadow on EQRx's drugs - Jefferies
Brief: EQRx Reports Fourth Quarter And Full Year 2021 Financial Results
Brief: EQRx Announces Two Lancet Oncology Publications Of Phase 3 Results Of Sugemalimab In Stage III And IV Non-Small Cell Lung Cancer
Brief: EQRx Enters Memorandum Of Understanding With CVS Health
Brief: EQRx And Geisinger Sign MoU To Provide Access To Innovative Cancer Medicines At Radically Lower Costs
Brief: Eli Casdin Reports 11.4% Stake In EQRX Inc As Of Dec 17
Biotech EQRx sinks after lackluster debut
U.S. STOCKS ON THE MOVE-Insurance stocks, Zhihu, Cerner Corp, Robinhood
SoftBank-backed biotech EQRx falls after deSPACing
Brief: EQRx Presents Phase 3 Data Of Lung Cancer Treatment At ESMO Congress
Brief: Eqrx Appoints Richard Buckley As Chief Corporate Affairs Officer
U.S. STOCKS ON THE MOVE-Yelp, GoPro, Switch
CM Life Sciences III rises on deal to take EQRx public
NASDAQ RESUMED AT 07:30 AM
NASDAQ RESUMED AT 07:30 AM
Brief: CM Life Sciences III Inc Says Melanie Nallicheri Has Been Appointed Chief Executive Officer Of Eqrx